Ellipses Pharma
Clinical trials sponsored by Ellipses Pharma, explained in plain language.
-
New hope for Tough-to-Treat leukemias: experimental drug enters human trials
Disease control Recruiting nowThis early-stage study is testing a new oral drug called EP0042, both alone and combined with other cancer treatments, in adults with advanced blood cancers like acute myeloid leukemia (AML). The main goal is to find a safe and tolerable dose. The study is for patients whose canc…
Phase: PHASE1, PHASE2 • Sponsor: Ellipses Pharma • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug targets resistant cancers in groundbreaking trial
Disease control Recruiting nowThis study is testing a new drug called EP0031 for people with advanced cancers that have specific RET gene changes, including lung cancer. The goal is to find the right dose and see if the drug is safe and effective, especially for patients whose cancer has stopped responding to…
Phase: PHASE1, PHASE2 • Sponsor: Ellipses Pharma • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug trial targets Tough-to-Treat breast cancer
Disease control Recruiting nowThis study is testing a new drug called EP0062, both alone and combined with standard treatments, for women with a specific type of advanced breast cancer that has come back after prior therapy. The main goals are to find the safest and most effective dose and to see how well the…
Phase: PHASE1, PHASE2 • Sponsor: Ellipses Pharma • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC